Re: Masayuki Hagiwara, Atsushi Fushimi, Kazuhiro Matsumoto, Mototsugu Oya. The Significance of PARP1 as a Biomarker for Predicting the Response to PD-L1 Blockade in Patients with PBRM1-mutated Clear Cell Renal Cell Carcinoma. Eur Urol. 2022;81:145-8

Eur Urol. 2022 Mar;81(3):e65. doi: 10.1016/j.eururo.2021.11.033. Epub 2021 Dec 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • B7-H1 Antigen / genetics
  • Biomarkers
  • Carcinoma, Renal Cell* / drug therapy
  • Carcinoma, Renal Cell* / genetics
  • Carcinoma, Renal Cell* / pathology
  • DNA-Binding Proteins
  • Female
  • Humans
  • Kidney Neoplasms* / drug therapy
  • Kidney Neoplasms* / genetics
  • Kidney Neoplasms* / pathology
  • Male
  • Poly (ADP-Ribose) Polymerase-1
  • Transcription Factors

Substances

  • B7-H1 Antigen
  • Biomarkers
  • DNA-Binding Proteins
  • PBRM1 protein, human
  • Transcription Factors
  • PARP1 protein, human
  • Poly (ADP-Ribose) Polymerase-1